"Estriol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol.
| Descriptor ID |
D004964
|
| MeSH Number(s) |
D04.210.500.365.415.331 D06.472.334.851.437.750
|
| Concept/Terms |
Estriol- Estriol
- 16alpha,17beta-Estriol
- 16alpha,17beta Estriol
- (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol
- 16-alpha-Hydroxy-Estradiol
- 16 alpha Hydroxy Estradiol
Epiestriol- Epiestriol
- 16beta-Hydroxy-Estradiol
- 16beta Hydroxy Estradiol
- (16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol
- Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol
|
Below are MeSH descriptors whose meaning is more general than "Estriol".
Below are MeSH descriptors whose meaning is more specific than "Estriol".
This graph shows the total number of publications written about "Estriol" by people in this website by year, and whether "Estriol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 2 | 2 |
| 2002 | 2 | 0 | 2 |
| 2005 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estriol" by people in Profiles.
-
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study. Gynecol Oncol. 2022 03; 164(3):481-491.
-
Simultaneous determination of four trace estrogens in feces, leachate, tap and groundwater using solid-liquid extraction/auto solid-phase extraction and high-performance liquid chromatography with fluorescence detection. J Sep Sci. 2015 Oct; 38(20):3494-501.
-
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers. Am J Obstet Gynecol. 2008 Sep; 199(3):290.e1-6.
-
Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J. 2008 Sep; 22(9):3328-36.
-
Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol. 2008 Nov; 199(5):506.e1-7.
-
Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol. Am J Med Genet A. 2005 Sep 15; 138(1):56-60.
-
Low or absent unconjugated estriol in pregnancy: an indicator for steroid sulfatase deficiency detectable by fluorescence in situ hybridization and biochemical analysis. Prenat Diagn. 2002 Nov; 22(11):1028-32.
-
Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol. 2002 Mar; 124(1-2):106-14.
-
Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. J Clin Epidemiol. 1999 Jun; 52(6):517-22.
-
Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci U S A. 1999 Mar 30; 96(7):3999-4004.